Peripheral Neuropathy Trial, Recruiting NCT03810768 Sponsor: Technical University of Munich Condition: Peripheral Neuropathy
Back to Peripheral Neuropathy

Peripheral Neuropathy Trial, Recruiting

NCT03810768
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are critically ill, on a breathing machine (mechanical ventilator), and expected to stay in the intensive care unit for more than 3 days
  • People who are recovering after surgery
  • People who are 18 years old or older
  • People who have been classified as having significant pre-existing health problems, based on a standard medical scoring system used by anesthesiologists (confirm with trial site)

Who may not be able to join:

  • People who are considered to be in the final stages of life with very little chance of survival
  • People who are receiving comfort-focused care rather than treatment aimed at recovery

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Stefan J Schaller, MD, Technical University of Munich

Phone: +4314040041020

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Technical University of Munich
Registry
ClinicalTrials.gov
Start date
2 September 2022
Est. completion
1 November 2026

Where this trial is recruiting

🇦🇹 Austria 🇩🇪 Germany

Primary endpoints

Metabolomics

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov